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ABSTRACT 18 
Coccidiosis penalizes Calcium (Ca), Phosphorus (P) and fat-soluble vitamin status, as well as 19 
bone mineralization in broiler chickens. We hypothesized that dietary vitamin D (VitD) 20 
supplementation in the form of 25-hydroxycholecalciferol (OHD), compared to cholecalciferol 21 
(D3), would improve bone mineralization in broilers receiving marginally deficient Ca/P diets, 22 
with more pronounced effects during malabsorptive coccidiosis. In a 2 VitD source × 2 Ca/P 23 
levels × 2 levels of infection factorial experiment (n=6 pens per treatment, 6 birds/pen), Ross 24 
308 broilers were assigned to an Aviagen-specified diet supplemented with 4000IU/kg of either 25 
OHD or D3 between d11 to 24 of age. The diet contained adequate (A; 8.7:4.4g/kg) or 26 
marginally deficient (M; 6.1:3.1g/kg) total Ca and available (av)P levels. At d12 of age, birds 27 
were inoculated with water (C) or 7,000 Eimeria maxima oocysts (I). Pen performance was 28 
measured over 12 days post-infection (pi). One bird per pen was assessed for parameters of 29 
bone mineralization and intestinal histomorphometric features (d6 and 12pi), as well as E. 30 
maxima replication and gross lesions of the small intestine (d6pi). There was no interaction 31 
between infection status and Ca/avP level on bone mineralization. Bone breaking strength (BS), 32 
ash weight (AW) and ash percentage (AP) were highest in broilers fed the OHD-supplemented 33 
A diets irrespective of infection status. E. maxima infection impaired (P < 0.05) ADG and FCR 34 
pi; Ca and P status at d6pi; OHD status, BS, AW and AP at d12pi; and intestinal morphology 35 
at d6 and 12pi. A- compared to M-fed broilers had higher BS, AW and AP at d6pi, and AW at 36 
d12pi. VitD source affected only OHD status, being higher (P < 0.001) for OHD- than D3-fed 37 
broilers at d6 and 12pi. In conclusion, offering OHD and adequate levels of Ca and P improved 38 
bone mineralization, with no effect on performance. Dietary D3 and OHD supplemented at 39 
4000IU/kg had similar effects on coccidiosis-infected and uninfected broilers, which led to the 40 
rejection of our hypothesis. 41 
Keywords: Broiler coccidiosis, cholecalciferol, 25-hydroxycholecalciferol, bone mineral, 42 
skeletal integrity. 43 
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INTRODUCTION 44 
Vitamin D (VitD) nutrition plays a critical role in Calcium (Ca) and Phosphorus (P) 45 
metabolism, bone mineralization, and other physiological processes related to performance and 46 
immunity against infections in broiler chickens (Whitehead et al., 2004; Khan et al., 2010; Shao 47 
et al., 2019). Studies have shown that higher-level supplementation and replacing the 48 
conventional source of dietary VitD (cholecalciferol; D3) with its metabolite (25-49 
hydroxycholecalciferol; OHD), can amplify VitD effects for broilers (Fritts and Waldroup, 50 
2003; Fritts et al., 2004; Fritts and Waldroup, 2005). This is because D3 requires liver-located 51 
hydroxylases for its conversion to OHD, which is the major VitD circulated metabolite 52 
(Barchetta et al., 2012; Bergada et al., 2014), and OHD may be the preferred source in young 53 
animals where liver function has not reached its full adult capacity. Furthermore, OHD 54 
compared to D3 absorption is less fat dependent, occurs at a faster rate, and more efficiently 55 
(Bar et al., 1980; Maislos et al., 1981). The above implies that OHD may be the preferred dietary 56 
source of VitD in young broilers, as well as during malabsorptive conditions, such as coccidia 57 
infections.  58 
Malabsorptive coccidiosis adversely affects aspects of bone mineralization in broilers 59 
(Sakkas et al., 2018a), and is linked to reduced absorption of Ca and P (Turk, 1973; Turk, 1978), 60 
depressed levels of circulating OHD (Sakkas et al., 2019), and increase bone resorption (Akbari 61 
Moghaddam Kakhki et al., 2018). Furthermore, higher levels of VitD supply, and offering VitD 62 
in the form of OHD instead of D3, significantly improve bone mineralization, while reduced 63 
VitD supply penalizes long bone mineralization to a similar degree in coccidian-infected and 64 
uninfected broilers (Sakkas et al., 2019).  65 
In our recent study, lower VitD supplementation (1000 vs 4000 IU/kg) while offering 66 
Ca/P adequate diets reduced bone mineralization and growth performance with more significant 67 
penalties incurring amongst coccidiosis-infected than uninfected broiler (Sakkas et al., 2019). 68 
Moreover, OHD was more efficient at improving Ca and P absorption and OHD status at 69 
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comparable levels of D3 supplementation (Fritts and Waldroup, 2005; Sakkas et al., 2018b). 70 
Indeed, adequate levels of Ca and P in diets, as well as a Ca/P ratio from 1.8 to 2:1, are crucial 71 
for their retention by broilers (Rao et al., 2006; Delezie et al., 2015). 72 
There is increasing evidence of the need for P reduction in broiler diets for economic 73 
and environmental reasons (Knowlton et al., 2004; Wironen et al., 2018). This relates to the 74 
high prices of feed-grade P supplements but more importantly the environmental pollution 75 
caused by unutilized phytate phosphorus (PP) excretion. PP also chelates essential minerals 76 
including Zinc, Copper, Iron and Magnesium in feedstuffs thereby limiting their availability to 77 
broilers, and increasing the amount of these minerals excreted into the environment (Reddy et 78 
al., 1982; Shafey et al., 1991; Maenz et al., 1999). Therefore, studies aiming to reduce the 79 
exogenous supply of P from phosphate sources focus on strategies for improving P, and 80 
invariably Ca, utilization via increased VitD supply, phytase enzyme supplementation, or both.  81 
This study investigated whether dietary VitD supply at commercially supplemented 82 
levels (4000 IU/kg) in the form of OHD, would result in improved bone mineralization for 83 
coccidia-infected broilers receiving marginally deficient Ca/P diets. We hypothesized that VitD 84 
supplementation in the form of OHD compared to D3 will promote bone mineralization due to 85 
improved Ca and P utilization, as well as enhance performance, for broilers on marginally deficient 86 
Ca and P diets; effects will be more pronounced in the presence of coccidiosis.  87 
 
MATERIALS AND METHODS 88 
Animals, Husbandry, and Diets 89 
All experimental procedures complied with the UK Animals (Scientific Procedures) Act 90 
1986, as well as the EU Directive 2010/63/EU for animal experiments, and were carried out under 91 
Home Office authorization (P441ADF04). Two hundred and eighty-eight male Ross 308 day old 92 
chicks were raised from hatch to 24 d of age. Birds were housed in 48 rectangular pens (0.84 m2) 93 
situated in a windowless thermostatically controlled building. Each pen was equipped with a tube 94 
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feeder and a bell-drinker, and wood shavings to a depth of 5 cm as litter. The temperature at pen 95 
level was monitored daily and maintained to meet Aviagen recommendations for spot brooding 96 
(Aviagen, 2014), starting at 34 °C at chick placement and gradually reduced to 20 °C by 24 d of age. 97 
Light intensity at pen level ranged from 60 to 80 lux, while a lighting schedule of 23L:1D was applied 98 
for the first 7 days of age and switched to 18L:6D for the remainder of the trial. Feed and water were 99 
offered to birds ad libitum for the duration of the experiment. Upon arrival, birds were allocated to a 100 
standard starter (d1 to 10) and then to a grower (d11 to 24) diet (see Table 1), which offered either 101 
adequate (A) levels of total Ca and avP or marginally deficient (M) levels of approximately 30% 102 
below Aviagen recommendations. We classed the M as marginally deficient level because it has a 103 
similar effect on the performance of broilers as the Aviagen-recommended A levels, but results in 104 
reduced bone mineralization (Rao et al., 2006; Delezie et al., 2015; Valable et al., 2018). Hence, 105 
there were four dietary treatments; AD3, MD3, AOHD, and MOHD. VitD was supplemented at 106 
4000 IU/kg as per commercial practice in the EU (Fritts et al., 2004) and is within the EFSA 107 
authorized limits (EFSA, 2012). The dietary specifications of the starter and the grower diets were 108 
according to Aviagen nutrition recommendations (Aviagen, 2014) apart from the total Ca and avP 109 
levels of M diets. Starter diets were offered in crumbled form with grower diets in pelleted form. We 110 
recorded pen health daily and two birds with gait scores of 4 were culled and euthanized. 111 
Experimental design and inoculations 112 
The experiment was arranged in a 2×2×2 factorial pattern with dietary VitD source (D3 vs 113 
OHD), Ca/P levels (adequate vs deficient) and infection status (control vs infected) of birds as the 114 
independent variables. The diets containing adequate total Ca and avP (A; 8.7: 4.4 g/kg), or deficient 115 
levels (M; 6.1: 3.1 g/kg) were introduced at 10 d of age, while all birds received 4000 IU/kg VitD 116 
either as D3 or OHD throughout the experiment. At 12 d of age, birds were orally inoculated with a 117 
single 0.5 ml dose of water (Control; C) or 7000 (Infected; I) sporulated E. maxima oocysts of the 118 
Weybridge laboratory reference strain, using 1ml syringes. The inocula were prepared at the Royal 119 
Veterinary College, University of London following previously described method (Pastor-120 
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Fernández et al., 2018).  The treatment groups were replicated in six pens stocked with six birds 121 
per pen. 122 
Sampling  123 
To assess performance, pen feed intake was measured post-infection (pi), and birds were 124 
individually weighed at infection (d0pi), and at time points (d6 and 12pi), representing the early and 125 
late stages of E. maxima infection in broilers. One bird per pen weighing close to pen average was 126 
selected at d6 and 12pi for blood sampling via the wing vein and subsequently euthanized with a 127 
lethal injection of sodium pentobarbitone (Euthatal®, Merial Harlow, United Kingdom). Blood 128 
samples were collected in 5 ml sodium heparin plasma tubes (BD Vacutainer, SST II Advance Plus 129 
Blood Collection Tubes-BD, Plymouth, United-Kingdom), then immediately placed on ice and 130 
centrifuged for 10 mins at 1500 g at 4 °C within 1.5 h after collection. Plasma sample aliquots were 131 
stored at -80 °C pending analyses. The gastrointestinal tract (GIT) of the selected birds was removed 132 
during necropsy and duodenum, jejunum and ileum were scored separately for any lesions, 133 
according to the method described by Johnson and Reid (1970). Following lesion scoring at d6pi, 6 134 
cm of intestinal tissue from the immediate region of Meckel’s diverticulum, the mid-point of the 135 
intestinal area infected by E. maxima (Long et al., 1976), was excised and opened longitudinally to 136 
remove fecal contents. Excised tissue (5 cm) was submerged in 7 ml bizous, and 1 cm in 1.5 ml 137 
screw cap microtubes (Thermo Scientific) filled with RNAlater® (Life Technologies; Carlsbad, CA, 138 
USA) and stored at -80 oC pending analyses. Thereafter, three segments of 1 cm each from the 139 
duodenal loop, mid-jejunum (midway between Merkel's diverticulum and the end of the 140 
duodenal loop) and mid-ileum (midway between Merkel's diverticulum and the ileocecal 141 
junction) were sampled from birds dissected on d6 and d12pi and fixed in 10% buffered 142 
formalin pending microscopic morphological assessment. Following GIT removal, right femur 143 
and tibia of the selected birds were dissected to evaluate physical development and mineralization. 144 
Much of the adhering tissues were removed from dissected bones before storing in airtight 145 
individually labeled polyethylene bags at -20 °C pending evaluation. 146 
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Sample analysis 147 
Experimental diet. Feed samples were analyzed for VitD3 and OHD contents at the DSM 148 
Laboratory (Basel, Switzerland) using the same method as Schadt et al. (2012). The analyzed D3 149 
and OHD contents of the experimental diets were 4910 and 2828 IU/kg (starter) and 4520 and 2720 150 
IU/kg (grower), respectively.  151 
Blood metabolites. Concentrations of Ca and P (mmol/l) in blood plasma were analyzed in 152 
duplicate using an ABX Horiba Pentra 400 automatic analyzer (Horiba Medical, Irvine, CA, USA) 153 
according to manufacturer’s instructions. Plasma concentration of OHD (ng/ml) was determined 154 
using the 25-Hydroxy Vitamin D Direct EIA kit (IDS Diagnostics, Fountain Hills, AZ, USA) 155 
according to manufacturers’ instructions. 156 
Morphometry analysis. The same method described in Sakkas et al. (2018a) was used. 157 
It involved gradual dehydration of sampled formalin-fixed duodenal, jejunal and ileal tissues in 158 
ethanol (50, 75, 95, and 100%) followed by xylene. After that, each tissue was embedded in 159 
paraffin wax, 4µm sections were cut, put in slides, gradual rehydration in ethanol (100, 80, 70, 160 
and 50%), rinsed in water, stained in hematoxylin and then counterstained in eosin. Slides were 161 
scanned with Leica SCN400 slide scanner, Germany (Software version: SlidePath Gateway Client 162 
Viewer 2.0) at 20× magnification and then villus length and crypt depths of stained sections were 163 
measured using ImageScope® software (Aperio Technologies, Vista, CA, USA).  164 
  Bone evaluation. Bones were thawed at 4 oC overnight and place at room temperature for 165 
1 h before the adhering soft tissues were removed. Using a digital calliper, length, and diameter 166 
(maximum and minimum) at the centre of the diaphysis were measured for tibia and femur, and then 167 
the weight of each bone was measured using an analytical balance. Robusticity (Riesenfeld, 1972) 168 
and Seedor indices (Seedor et al., 1991) were calculated using the following formulas;  169 
Robusticity index =
bone length (mm)
bone weight (mg)1/3
 170 
Seedor index =
bone weight (mg)
bone length (mm)
 171 
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The bones were subjected to a 3-point break test using an Instron testing machine (Instron 172 
3340 Series, Single Column-Bluehill, Norwood, USA). The testing support consisted of an 173 
adjustable 2-point block jig, spaced at 30 mm for both tibia and femur bones. The crosshead 174 
descended at 5 mm/min until a break was determined by measuring a reduction in force of at least 175 
5%. After assessing breaking strength (BS, N), tibia and femur bones were boiled for 5 mins in 176 
deionized water at 100 oC to facilitate removal of cartilage caps, split in two for manual removal of 177 
bone marrow, and further broken into smaller bits. After that, bones were placed in vessels 178 
containing 10 ml of acetone (VWR) and 10 ml of petroleum ether (VWR) and were subjected 179 
to fat extraction in a Mars 6 Microwave Assisted Reaction System 6 (CEM, Matthews, USA) 180 
with a set temperature of 180 °C for 80 mins. Fat extracted bones were then place in an oven at 181 
105 °C for 18 h and were weighed to obtain the dry defatted bone weight (DDB, g). Finally, 182 
DDB were placed in a Phoenix CEM ashing microwave furnace (CEM, Matthews, USA) at 850 183 
°C for 1.5 h to obtain the ash weight (AW, g) and then ash percentage (AP).  184 
Quantitative real-time PCR (qPCR) 185 
Eimeria maxima Genome Copies. The same procedure described in Sakkas et al. 186 
(2018a) was followed.  187 
Calculations and Statistics 188 
All statistical analyses were conducted using IBM SPSS Statistics for Windows, 189 
Version 22.0. (Armonk, NY: IBM Corp). Pen was considered the experimental unit for all 190 
statistical assessments. Broiler ADFI (g/d), ADG (g/d) and FCR were calculated pre-infection 191 
(i.e., d0 to 10 and d11 to 12 post-hatch), over the entire period pi (d1 to 12pi), as well as for the 192 
early (d1 to 6pi) and late (d7 to 12pi) stages of infection. Furthermore, BW, ADG, and ADFI 193 
pi were expressed in proportion to BW at infection (BWd0pi) to account for the diet-change-194 
induced tendencies of a priori differences in BW at infection, and because BW and ADFI 195 
increased proportionally with age. Data were analyzed with VitD source, level of Ca/P supply 196 
and infection status as fixed factors, and their interactions using the GLM. The concentration of 197 
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Ca, P and OHD in blood plasma, villi height (VL), crypt depth (CD), and villi height/crypt depth 198 
ratio (VCR), parasite replication, and all bone-derived data generated from birds sampled at d6 and 199 
12pi were also analyzed with the above factors using GLM. When significant differences were 200 
detected, treatment means were separated and compared by the Tukey’s multiple comparison test. 201 
The Shapiro-Wilk test was used for assessing the normality of the studentized residuals and 202 
non-normalised data, such as plasma OHD concentration and parasite genome copy numbers, 203 
were log-transformed before statistical analysis. The log-transformed values are presented. 204 
Significance was determined at P < 0.05 and tendencies at P < 0.1. Intestinal lesion score was 205 
evaluated on a scale of 0 (no lesion) to 4 (very severe lesions); 1, 2 and 3 represented mild, moderate 206 
and severe lesions respectively, while a score of 4 was not observed. As only infected birds had 207 
lesions, data were analyzed with Ca/P level and source of VitD supply as fixed variables and their 208 
interaction, using the ordinal logistic regression procedure of SPSS.  209 
 
RESULTS 210 
Performance variables 211 
The main effects of dietary VitD source, Ca/P level and infection status on performance: 212 
BW, ADG, ADFI, and FCR pre-infection and pi are presented in Tables 2 to 4. There were no 213 
significant 2- or 3-way interactions (P > 0.05) between the experimental factors for 214 
performance variables in this study. Also, no performance variable was affected by VitD source 215 
(P > 0.1). 216 
Pre-infection. VitD source did not affect (P > 0.1) performance over the starter period 217 
(d0 to 10 of age). However, between d11 and 12 of age when dietary Ca/P levels were altered, 218 
birds receiving the M in comparison to the A diets had higher ADFI (P = 0.006), ADG (P = 219 
0.069) and higher BW (P = 0.067) at d12 of age (Table 2).  220 
Post-infection period. Infection reduced (P < 0.001) ADG and ADFI, and increased 221 
FCR (P = 0.005) calculated over the infection period (d1 to 12pi). BW at d12pi was reduced 222 
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(P < 0.001) for I compared with C birds. Ca/P levels affected ADG pi (P = 0.037), as well as 223 
BW (P = 0.020) at d12pi; values were higher for birds receiving the M in comparison to the A 224 
diets (Table 3).  225 
Early and late stages of infection. Infection with E. maxima impaired (P < 0.05) ADG, 226 
ADFI, and FCR during the early and late stages of infection, while the effect of Ca/P level on 227 
these variables was not significant (P > 0.05) during both stages. Moreover, ADG (P = 0.086) 228 
and ADFI (P = 0.076) tended to be higher for the M- than the A-fed broilers during the early 229 
stage (d0 to 6pi) of infection (Table 4). VitD source and infection status also tended to interact 230 
(P = 0.052) for ADG per unit BW d0pi during the early stage of infection: values for OHD- 231 
compared to D3-fed broilers tended to be higher amongst control birds, but lower amongst 232 
infected birds.   233 
Plasma Ca, P and OHD concentrations  234 
The main effects of dietary VitD source, Ca/P level, and infection status on plasma Ca, 235 
P, and OHD concentrations are presented in Table 5. There was no 3-way interaction between 236 
the experimental factors for Ca and P status at d6 and 12pi. The 2-way interaction effects (P = 237 
0.014) between VitD source and infection status for Ca at d6pi is given in Figure 1. Amongst 238 
control birds, plasma Ca was significantly higher for birds receiving OHD than D3 diets, while 239 
D3 and OHD diets had a similar effect on plasma Ca concentration for infected birds. There 240 
were no other 2-way interactions between the experimental factors.  241 
Infection reduced (P < 0.05) Ca and P concentration (mmol/l) in the blood plasma of 242 
broilers only at d6pi, while VitD source and Ca/P level had no significant effect on Ca or P 243 
status at both d6 and12pi. Infection reduced (P < 0.05) plasma OHD concentration (ng/ml) at 244 
d6 and d12pi. Broilers receiving OHD compared to D3 diets had higher (P < 0.05) plasma OHD 245 
concentration at d6 and d12pi. Ca/P level tended to increase (P = 0.098) plasma OHD 246 
concentration for M- compared to A-fed broilers at d6pi, but did not affect OHD status at 12pi 247 
(Table 5). 248 
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Histology and lesion scores 249 
 Histology. Results of duodenum, jejunum, and ileum morphological analysis are 250 
presented in Table 6. There were no significant 2- or 3-way interaction (P > 0.05) between 251 
dietary VitD source, Ca/P level, and infection status for VL, CD or VCR in any section of the 252 
small intestine at d6 or 12pi. Dietary VitD source and Ca/P level did not affect (P > 0.05) small 253 
intestine morphological architecture assessed at d6 and 12pi. 254 
 Infection reduced (P < 0.05) duodenal VL at d6 and 12pi, and jejunal VL at d6pi. 255 
Infection increased (P < 0.05) jejunal and ileal CD at d6 and 12pi, and duodenal CD only at 256 
d6pi. Furthermore, infection reduced (P < 0.05) VCR of duodenum, jejunum and ileum at d6 257 
and d12pi (Table 6). 258 
 Lesion score. Uninfected broilers had no visible intestinal lesions. The effects of 259 
dietary VitD source, Ca/P level, and their interaction was not significant (P > 0.05) for 260 
duodenal, jejunal or ileal lesion scores for infected broilers in this study. Nevertheless, E. 261 
maxima lesions occurred across all three sections of the small intestine with severe lesions 262 
(score 3) occurring only in the jejunum. The duodenum had mild lesions (score 1) only while 263 
the ileum had mild to moderate lesions (score 2).  264 
Parasite replication 265 
There were no E. maxima genome copies detected in the gut of C birds at the point of 266 
sampling; d6pi. There was no interaction (P > 0.05) between Ca/P level and VitD source for E. 267 
maxima genome copy number. M and A diets (M = 5.16 vs A = 5.32; SEM = 0.0692), as well 268 
as D3 and OHD VitD sources (D3 = 5.34 vs OHD = 5.16; SEM = 0.0692) had no effect (P > 269 
0.05) on parasite replication or broilers. 270 
Bone evaluation  271 
The main effects of dietary VitD source, Ca/P level, and infection status on bone 272 
variables are presented in Tables 7 and 8. Any significant 2-way interactions between 273 
experimental factors on bone variables are reported below. There was no significant 3-way 274 
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interaction between the experimental factors while the main effect of VitD source was not 275 
significant (P > 0.05) for all femur and tibia parameters assessed in this study.  276 
 Linear growth in proportion to BW. Dietary Ca/P level interacted with infection status 277 
(P = 0.035) for relative tibia length, i.e. in proportion to body weight at dissection (length/BW), 278 
at d6pi. Infected birds receiving the M compared to the A diets had lower tibia length/BW 279 
values (P < 0.05), which were statistically similar to values for C birds receiving M or A diets.  280 
 Infection increased (P < 0.05) femur length/BW at d6 and d12pi, as well as femur 281 
width/BW at d6 and d12pi (Table 7). Infection also increased (P < 0.05) tibia length/BW at d6 282 
and d12pi, and tibia width/BW at d6pi (Table 8).  283 
 Dietary Ca/P level affected tibia and femur linear growth only at d6pi. M compared to 284 
A diets reduced (P < 0.05) width/BW of tibia and femur (Tables 7 and 8).  285 
 Breaking strength in proportion to BW. Ca/P level in diet interacted with infection 286 
status (P = 0.024) for tibia BS in proportion to body weight d12pi. C birds offered A compared 287 
to M diets had significantly higher values while BS/BW of infected A and M birds were 288 
statistically similar. Infection reduced BS/BW (P < 0.05) of tibia and femur only at d12pi 289 
(Tables 7 and 8). M diet reduced (P < 0.05) tibia and femur BS/BW compared to A diet at d6pi. 290 
BS/BW values remained lower (P < 0.05) for tibia and femur of M- than A-fed broilers at d12pi 291 
(Tables 7 and 8). 292 
Weight/length (Seedor) and robusticity indices. Dietary Ca/P level interacted with 293 
infection status (P < 0.05) for tibia and femur seedor and robusticity indices only at d12pi. In 294 
general, results of both indices show that tibia and femur density amongst birds receiving the 295 
A diet were significantly higher for the C than the I birds. On the other hand, tibia and femur 296 
density were statistically similar for C and I birds receiving the M diets. Infection reduced (P 297 
< 0.05) seedor index of tibia and femur at d12pi, while the main effect of dietary Ca/P level on 298 
tibia and femur seedor or robusticity indices was not statistically significant (Tables 7 and 8).   299 
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Ash percentage and ash in proportion to BW. VitD source and Ca/P level interacted 300 
(P < 0.05) for tibia AP and AW/BW only at d12pi. Amongst broilers receiving OHD diets, AP 301 
and AW/BW values were significantly reduced for birds offered the M compared to the A diets. 302 
These reduced values for MOHD birds were at statistically similar levels as the AP and 303 
AW/BW values for birds receiving the MD3 and AD3 diets. Infection reduced (P < 0.05) tibia 304 
AW/BW only at d12pi, and AP at d6 and d12pi for I in comparison to C birds (Table 8). Dietary 305 
Ca/P level affected (P < 0.05) tibia AW/BW at d6 and 12pi, and tibia AP at d6pi. M- compared 306 
to A-fed broilers had reduced (P < 0.05) tibia AW/BW at d6pi and d12pi, as well as AP at d6pi 307 
(Table 8). 308 
 
DISCUSSION 309 
We aimed at inducing a marginal Ca and P deficiency in growing broilers to test the 310 
hypothesis that dietary VitD supplementation at 4000 IU/kg using OHD instead of D3 will 311 
enhance long bone mineralization and productive performance of broilers on such diets during 312 
coccidiosis. We additionally hypothesized more pronounced effects of VitD source in the 313 
coccidiosis-infected than in the uninfected broilers. We anticipated a 3-way interaction between 314 
VitD source, Ca/P level and infection status, as well as a 2-way interaction between VitD source 315 
and Ca/P level, for parameters of long bone mineralization and performance of broilers in this 316 
study. The higher biological potency of OHD in mediating VitD activity compared to D3 317 
(Wagonfeld et al., 1976; Reed et al., 1980; Fritts and Waldroup, 2003), and the observed 318 
impairment of bone mineralization following malabsorptive coccidian infections (Sakkas et al., 319 
2018a) formed the basis of our hypothesis. Furthermore, we investigated whether OHD 320 
compared to D3 would affect parasite replication and its effect on intestinal gut integrity during 321 
broiler coccidiosis. 322 
Although the analyzed OHD levels in the experimental diets were consistently lower 323 
than the intended values, the cause of this may likely be analytical as observed in our previous 324 
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study (Sakkas et al., 2019): we used the same laboratory and equipment to analyze feed samples 325 
in both studies. Notwithstanding, blood OHD concentration, an indicator of dietary VitD intake 326 
(Hollis, 2005; Autier et al., 2014), were consistently and significantly higher for broilers 327 
receiving the OHD compared to the D3 diets in accordance with our aims and hypothesis. 328 
Therefore, we are confident to discuss the results presented herein without any reservations in 329 
this regard. Also, we attained the expected effects of the Ca/P levels on parameters of long bone 330 
mineralization: femur and tibia BS (d6 and 12pi), as well as tibia ash weight (d6 and 12pi) and 331 
ash percentage (d6pi), were reduced significantly for the M compared to the A-fed broilers. 332 
Furthermore, E. maxima infection significantly impaired performance and long bone 333 
mineralization, and altered gut morphological features as expected from our previous broiler 334 
coccidiosis study (Sakkas et al., 2018a).  335 
In the present trial, we assessed circulating OHD as a marker for VitD status because it 336 
is the main storage form of the Vit in animals and research has shown that it is a more accurate 337 
indicator of VitD nutritional status than the biologically active metabolite, 1,25D3 (Yarger et 338 
al., 1995; Young et al., 1997; Norman, 2008). A reason for the above is that the formation 339 
process of OHD from D3 in the liver is not regulated, so blood level rightly reflects dietary 340 
intake. Conversely, renal or extra-renal production of 1,25D3 from OHD is tightly regulated; 341 
being influenced by several factors including circulating Ca, P and parathyroid and other related 342 
hormones (Holick, 2005; Hollis and Horst, 2007; Autier et al., 2014).  343 
The poorer performance, regarding BW, ADG, ADFI, and FCR, of the I than the C 344 
broilers reported herein, is traceable to several factors including pathogen-induced anorexia 345 
(Kyriazakis, 2014), impaired nutrient absorption and utilization (Hernández-Velasco, et al., 346 
2014; Preston-Mafham and Sykes, 1970; Rochell, et al., 2016) associated with the parasite-347 
induced morphological alterations in the small intestine (Sakkas et al., 2019). The penalized 348 
performance may also be attributed to the activation of an immune response (Allen, 1997) 349 
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amongst other disease-related expenditures such as altered expression of nutrient transporters 350 
and digestive enzymes in the intestine (Su et al., 2015).   351 
We anticipated the absence of an effect of dietary Ca/P level on relative ADG and ADFI 352 
in the current study. This is because 25 to 33% and 15 to 23% reductions of dietary total Ca and 353 
of avP respectively, below the recommended levels (Aviagen, 2014), whilst maintaining a Ca/P 354 
ratio close to 2:1, have not previously penalize growth performance in growing broilers (10 to 355 
30 days of age) (Delezie et al., 2012; Delezie et al., 2015; Valable et al., 2018). Valable et al. 356 
(2018) suggested that this lack of effect on growth performance is because a decrease in Ca and 357 
avP at the levels mentioned above reduces lean body content and increases body fat content. It 358 
is expected that effects on bone mineralization would be seen before the impact on performance 359 
because Ca and P requirements for mineralization exceed those for lean body mass development 360 
(Larbier and Leclercq, 1992).  361 
The absence of a significant 3-way interaction between Ca/P level, VitD source and 362 
infection status for any of the measured variables in this study led to the rejection of our 363 
hypothesis. Our results, therefore, suggested a similar effect of dietary OHD and D3 364 
supplemented at 4000 IU/kg, on long bone quality, growth performance, and gut morphology 365 
of broilers infected with E. maxima or not. Previous studies (Fritts and Waldroup, 2003; Sakkas 366 
et al., 2018b) had reported a similar capacity for OHD and D3 to mediate VitD activities in 367 
healthy birds when supplied at the level in the current study. It is difficult to explain why the 368 
effects of OHD and D3 on bone mineralization did not differ due to coccidian infection that led 369 
to impaired Ca and P status, amongst birds offered deficient or adequate Ca/P diets. However, 370 
this suggests that coccidiosis also impairs the utilization of these nutrients for bone 371 
mineralization.  372 
The infection-induced reductions in plasma concentrations of Ca, P and OHD in the 373 
current study are consistent with our previous findings (Sakkas et al., 2019). In the present 374 
study, VitD source did not affect plasma Ca status in infected broilers, whereas OHD- in 375 
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comparison to D3-fed broilers had higher plasma Ca concentration amongst uninfected broilers. 376 
This interaction between VitD source and infection status that occurred for plasma Ca at d6pi 377 
was implicated in the similar VitD source and infection status interaction that occurred for tibia 378 
BS at d12pi. It was also connected with the 2-way interaction between VitD source and Ca/P 379 
level for tibia AP and AW/BW at d12pi in this study: values for AD3, MD3 and MOHD were 380 
statistically similar but significantly lower than AOHD. The specific mechanism by which 381 
OHD and D3 diets can have similar effects on plasma Ca status for coccidia-infected, but not 382 
for healthy broilers, as shown in the current study remains unclear. However, similar to the 383 
effects of phytase reported in Watson et al. (2005), these results suggest that OHD compared to 384 
D3 is more efficient in improving Ca and P absorption in the absence of coccidiosis, and that 385 
Ca and P utilization may be impaired by coccidiosis. The above finding for the control birds 386 
agreed with the hypothesis of the current study, but that for the infected birds warrants further 387 
investigations.  388 
As expected, we observed that the OHD- compared to the D3-fed broilers had 389 
significantly higher OHD concentration in blood plasma at d6 and 12pi, but this was the case 390 
irrespective of bird infection status and dietary Ca/P level. Although plasma OHD status of 391 
birds may be influenced by VitD content of the diet ingested, there is no evidence to suggest 392 
any correlation between concentrations of blood OHD and its biologically active metabolite, 393 
1,25D3, in broilers (Yarger et al., 1995). In line with Yarger et al. (1995), despite the higher 394 
plasma OHD concentration for the OHD- than the D3-fed broilers, the effects of VitD source 395 
on measured variables did not always reflect this in the current study. This offers a likely 396 
explanation as to why the main effect of VitD source was not significant for parameters of bone 397 
mineralization (BS, AW, and AP) or development (linear growth and density) in this study. 398 
However, we noticed that the combination of OHD and A diets in comparison to the other diet 399 
combinations significantly increased long bone mineralization for broilers as discussed in the 400 
preceding paragraph. 401 
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Consistent with the delayed effect of infection on BS in relation to performance reported 402 
previously (Sakkas et al., 2018a), E. maxima infection significantly weakened long bone BS of 403 
broilers at d12pi in the current study. There was a corresponding significant reduction in tibia 404 
AP for the infected than uninfected broilers at d6 and 12pi and AW/BW at d12pi. However, 405 
contrary to our expectation, OHD and D3 supplemented at 4000 IU/kg affected bone 406 
mineralization to a similar degree in both infected and control broilers. This conflicting 407 
evidence likely stem from the fact that the higher potency of OHD compared to D3 is better 408 
displayed when offering diets with suboptimal (< 500IU/kg) VitD levels (Fritts and Waldroup, 409 
2003; Fritts et al., 2004; Fritts and Waldroup, 2005). Similar to our findings, previous studies 410 
reported a reduction in bone mineral content, AP in DDB, and BS in the absence of effects on 411 
performance when offering diets with suboptimal levels of Ca and avP at a steady 2:1 ratio 412 
(Yan et al., 2005; Valable et al., 2018). 413 
A significantly higher parasite burden for OHD than D3 broilers observed in a previous 414 
study (Sakkas et al., 2019) was absent in the current study, although the total parasite replication 415 
was almost double in this study. However, the results herein are in line with previous report 416 
that dietary D3 and OHD mediate VitD functions similarly when supplemented at 4000 IU/kg 417 
(Fritts and Waldroup, 2003; Fritts et al., 2004; Sakkas et al., 2018b). A possible reason why 418 
4000 IU/kg OHD and D3 diets had similar effects on parasite replication in this study may be 419 
connected to the significantly higher parasite load herein. It may be the case that VitD 420 
immunomodulatory effects are more pronounced at lower levels of E. maxima replication, or 421 
that the outcome of a higher level of infection was influenced by the Eimerian crowding effect 422 
(Williams, 2001), possibly negating any experimental differences. Further studies will unravel 423 
this, as the scientific literature has no specific information on this to our knowledge. 424 
In conclusion, E. maxima infection and offering marginally deficient diets in Ca/P 425 
reduced bone mineralization. Broilers offered OHD as the source of dietary VitD and adequate 426 
Ca/P diets showed the highest degree of bone mineralization. However, our hypothesis that 427 
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high-level (4000 IU/kg) dietary OHD instead of D3 supplementation will enhance 428 
mineralization to a higher degree in E. maxima-infected than in uninfected broilers was rejected. 429 
The effect of dietary D3 and OHD on parameters of long bone mineralization that was similar 430 
for broilers irrespective of infection status suggests that the high-level OHD and D3 diets used 431 
in commercial broiler production might not affect E. maxima replication differently.  432 
 433 
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TABLES AND FIGURES 588 
Table 1 Ingredients with chemical composition of the starter (d0–10) and the two grower (d11–24) diets offered to birds. 589 
The nutrient composition was in accordance with Aviagen nutrient specifications (Aviagen, 2014), but the two grower 590 
diets contained different levels of Ca and P: an adequate and a deficient level  591 
Item 
Starter Grower 
         Adequate                       Deficient 
Ingredient (%)   
Wheat           47.9           51.6                  52.5 
Corn           10.0           10.0                  10.0 
Soybean meal (48 % CP)           32.0           25.3                  25.3 
Soybean full fat  4.00 7.00 7.00 
Soy crude oil 1.84 2.32 2.32 
Dicalcium phosphate 1.82 1.60 0.87 
Limestone 0.77 0.67 0.45 
Vitamin and mineral premix  0.40 0.40 0.40 
DL methionine 0.33 0.30 0.30 
L-Lysine 0.27 0.25 0.25 
Sodium bicarbonate (27 %) 0.21 0.20 0.20 
Sodium chloride (39 %) 0.19 0.20 0.20 
L-Threonine 0.14 0.12 0.12 
Choline chloride (60 %) 0.05 0.05 0.05 
L-Valine 0.03 0.02 0.02 
 
Nutrient composition (%)1 
ME (kcal/kg) (calculated)      3,000      3,067            3,095 
Crude protein            23.1           21.37                 21.00 
Crude fat 5.03 4.87 5.12 
Crude fibre 2.39 2.13 2.22 
Ash 5.43 4.83 4.80 
Calcium 1.03 0.80 0.63 
Phophorus 0.74 0.62 0.55 
Available phosphorus (calculated) 0.48 0.44 0.30 
Sodium 0.18 0.15 0.15 
Manganese (mg/kg)         218         169               160 
1Analyzed nutrient composition (%) unless otherwise stated.  592 
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Table 2 Main effects of source of VitD supply (D3 vs OHD) and Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) 
on body weight (BW, g) at d10 and 12 of age, and on average daily feed intake (ADFI, g/d), average daily gain 
(ADG, g/d) and feed conversion ratio (FCR, ADFI/ADG) of broilers pre-infection with E. maxima 
      Pre-infection  
Experimental 
factors 
d0 to10 of age    d11 to 12 of age   
ADG ADFI FCR  BWd10  ADG ADFI FCR  BWd12 
Level 
M - - -   378   58.4 74.3 1.28   495 
A - - -  373  55.5 70.5 1.27  484 
Source 
D3 32.7 36.4 1.11  372  57.8 72.6 1.26  488 
OHD 33.4 36.6 1.10  379  56.1 72.2 1.29  491 
  
SEM 0.288 0.287 0.00591  2.96  1.08 0.943 0.0171  4.01 
 
 
 
Probabilities 
Level - - -  0.242  0.069 0.006 0.890  0.067 
Source 0.124 0.734 0.122  0.135  0.246 0.781 0.193  0.628 
Level × Source - - -   0.201   0.187 0.061 0.893   0.105 
SEM: Pooled standard error of the mean. 593 
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Table 3 Main effects of dietary VitD source (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4) and infection status in 
broiler chickens orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, on 
body weight (BW, g) at infection (BWd0pi) and d12 post infection (BWd012pi), and on average daily gain (ADG, g/d), 
feed intake (ADFI, g/d) and feed conversion ratio (FCR, ADFI/ADG) over the period post infection (d1 to d12pi). 
 
  
 
  Post-infection period (d1 to 12pi) 
Experimental factors 
BWd0pi 
(g) 
BWd12pi 
(g) 
Bwd12pi/BWd0pi 
ADFI 
(g/d) 
ADG 
(g/d) 
ADFI/ 
BWd0pi 
ADG/ 
BWd0pi 
FCR 
Level 
M 495 1510 3.05 119 84.6 0.241 0.171 1.85 
A 483 1461 3.03 115 81.5 0.238 0.169 1.86 
Source 
D3 488 1476 3.03 116 82.4 0.237 0.169 1.79 
OHD 490 1494 3.05 118 83.6 0.242 0.171 1.92 
Infection 
Control 484 1582 3.27 122 91.5 0.253 0.189 1.69 
Infected 493 1389 2.81 112 74.5 0.226 0.151 2.02 
 
 SEM 3.98 14.2 0.0208 1.84 0.993 0.00288 0.00175 0.078 
   
Probabilities 
Level 0.042 0.020 0.353 0.111 0.037 0.493 0.387 0.975 
Source 0.758 0.378 0.400 0.331 0.391 0.302 0.465 0.262 
Infection 0.100 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.005 
Level × Source 0.065 0.503 0.165 0.145 0.799 0.513 0.195 0.433 
Level × Infection 0.825 0.245 0.133 0.142 0.125 0.067 0.078 0.332 
Source × Infection 0.740 0.342 0.359 0.287 0.223 0.218 0.249 0.336 
Level × Source × Infection 0.167 0.131 0.760 0.407 0.210 0.941 0.863 0.548 
SEM: Pooled standard error of the mean 594 
The period from d1 to 12pi equates to d12 to 24 of age 595 
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Table 4 Main effects of source of VitD supply (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) and infection status in broiler 
chicken orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, on average daily feed 
intake (ADFI, g/d), average daily gain (ADG, g/d) and feed conversion ratio (FCR, ADFI/ADG) during the early (d0 to 6pi) and late 
(d7 to 12pi) stages post-infection (pi) 
Experimental factors 
Early stage (d0 to 6pi)  Late stage (d7 to 12pi) 
ADFI 
(g/d) 
ADG 
(g/d) 
ADFI/ 
BWd0pi 
ADG/ 
BWd0pi 
FCR   
ADFI 
(g/d) 
ADG 
(g/d) 
ADFI/ 
BWd0pi 
ADG/ 
BWd0pi 
FCR 
Level 
M 101 74.2 0.204 0.150 1.37   137 94.0 0.278 0.190 1.50 
A 96.6 71.6 0.200 0.148 1.37  133 91.8 0.276 0.190 1.47 
Source 
D3 97.9 72.6 0.201 0.149 1.35  134 91.8 0.274 0.188 1.50 
OHD 99.7 73.1 0.203 0.149 1.39  137 94.0 0.280 0.192 1.47 
Infection 
Control 102 78.9 0.211 0.163 1.30  143 104 0.295 0.216 1.39 
Infected 95.5 66.8 0.193 0.135 1.44  128 81.5 0.259 0.165 1.58 
  SEM 1.74 1.05 0.00284 0.00173 0.0189  2.29 1.40 0.00381 0.00268 0.015 
   Probabilities 
Level 0.076 0.086 0.290 0.478 0.741  0.224 0.267 0.805 0.992 0.100 
Source 0.455 0.712 0.473 0.793 0.172  0.320 0.263 0.302 0.321 0.224 
Infection 0.011 <0.001 <0.001 <0.001 <0.001  <0.001 <0.001 <0.001 <0.001 <0.001 
Level × Source 0.094 0.294 0.291 0.993 0.070  0.284 0.841 0.840 0.155 0.293 
Level × Infection 0.341 0.113 0.260 0.052 0.337  0.102 0.336 0.052 0.307 0.531 
Source × Infection 0.206 0.084 0.151 0.059 0.436  0.455 0.693 0.426 0.825 0.905 
Level × Source × Infection 0.724 0.084 0.972 0.305 0.395   0.288 0.442 0.669 0.893 0.680 
SEM: Pooled standard error of the mean. 596 
The period from d0 to 6pi and d7 to 12pi equates to d12 to 18, and d19 to 24 of age, respectively.597 
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Table 5 Main effects of source of VitD supply (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) and infection status in 
broiler chicken orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, on 
concentration of Calcium (mmol/l), Phosphorus (mmol/l) and log-transformed 25-hydroxyl cholecalciferol (OHD; ng/ml) in 
blood plasma on days 6 and 12 post-infection (pi). 
Experimental factors 
Calcium (mmol/l)   Phosphorus (mmol/l)   
25-hydroxy 
cholecalciferol(ng/ml)1 
d6pi d12pi  d6pi d12pi  d6pi d12pi 
Level 
M 2.73 2.86   1.82 1.86   2.08 1.91 
A 2.75 2.87  1.78 1.92  1.99 1.92 
Source 
D3 2.71 2.86  1.76 1.91  1.78 1.67 
OHD 2.78 2.87  1.84 1.87  2.29 2.15 
Infection 
Control 2.90 2.85  1.88 1.89  2.09 2.10 
Infected 2.58 2.88  1.71 1.89  1.98 1.73 
 
 SEM 0.0301 0.0255  0.0371 0.0400  0.0373 0.0479 
   Probabilities 
Level 0.691 0.723  0.436 0.312  0.098 0.883 
Source 0.099 0.740  0.125 0.534  <0.001 <0.001 
Infection <0.001 0.311  0.003 0.889  0.036 <0.001 
Level × Source 0.765 0.936  0.122 0.742  0.268 0.082 
Level × Infection 0.903 0.418  0.067 0.624  0.516 0.477 
Source × Infection 0.014 0.623  0.536 0.698  0.141 0.411 
Level × Source × Infection 0.598 0.900   0.701 0.634   0.711 0.546 
1Log-transformed values  598 
SEM: Pooled standard error of the mean. 599 
See Figure 1 for a graphical illustration of the interaction (P = 0.014) between VitD source and infection status on blood calcium concentration at d6pi. 600 
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Table 6 Main effects of source of VitD supply (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) and infection status in broiler chicken orally inoculated with 0 (Control) or 7000 sporulated 
oocysts of E. maxima (Infected) at d12 post hatch, on small intestine morphology on days 6 and 12 post-infection (pi) 
      Duodenum   Jejunum   Ileum 
Experimental factors 
Villi length 
(μm) 
Crypt depth 
(μm) 
Villi/Crypt ratio  
Villi length 
(μm) 
Crypt depth 
(μm) 
Villi/Crypt 
ratio 
 Villi length 
(μm) 
Crypt depth 
(μm) 
Villi/Crypt ratio 
d6pi d12pi d6pi d12pi d6pi d12pi   d6pi d12pi d6pi d12pi d6pi d12pi   d6pi d12pi d6pi d12pi d6pi d12pi 
Level 
M 1767 2016 255 204 9.15 11.0  880 1135 226 175 5.44 6.70  634 711 159 136 4.49 5.39 
A 1766 2131 268 185 8.57 12.1  957 1174 248 177 5.48 6.81  640 700 162 140 4.28 5.37 
Source 
D3 1761 2070 264 212 8.89 10.9  952 1140 239 183 5.69 6.42  626 711 162 135 4.25 5.48 
OHD 1772 2077 260 176 8.83 12.2  886 1168 234 169 5.23 7.09  647 700 158 141 4.53 5.27 
Infection 
Control 2113 2156 153 183 13.8 13.2  1099 1142 126 156 8.73 7.43  617 697 116 114 5.45 6.21 
Infected 1420 1991 370 205 3.88 9.90  738 1167 347 197 2.19 6.07  657 714 205 163 3.32 4.54 
 
 SEM 39.6 51.0 6.96 15.4 0.244 0.455  29.6 42.9 8.25 7.14 0.176 0.254  19.7 19.7 7.69 5.99 0.179 0.224 
   Probabilities 
Level 0.998 0.119 0.181 0.384 0.098 0.108  0.073 0.525 0.070 0.864 0.860 0.758  0.836 0.708 0.829 0.688 0.417 0.957 
Source 0.855 0.917 0.673 0.107 0.854 0.054  0.121 0.641 0.693 0.161 0.069 0.068  0.461 0.698 0.739 0.471 0.295 0.512 
Infection <0.001 0.028 <0.001 0.308 <0.001 <0.001  <0.001 0.683 <0.001 <0.001 <0.001 0.001  0.177 0.859 <0.001 <0.001 <0.001 <0.001 
Level × Source 0.070 0.457 0.318 0.871 0.223 0.645  0.821 0.122 0.962 0.356 0.347 0.535  0.966 0.103 0.475 0.155 0.294 0.392 
Level × Infection 0.853 0.388 0.806 0.247 0.213 0.690  0.320 0.306 0.362 0.235 0.128 0.657  0.668 0.968 0.571 0.598 0.506 0.842 
Source × Infection 0.559 0.906 0.338 0.280 0.693 0.266  0.754 0.137 0.473 0.589 0.488 0.794  0.864 0.379 0.945 0.588 0.815 0.383 
Level×Source×Infection 0.100 0.187 0.579 0.164 0.112 0.072   0.695 0.853 0.482 0.757 0.628 0.966   0.629 0.590 0.780 0.554 0.661 0.325 
SEM: Pooled standard error of the mean. 601 
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Table 7 Effects of source of VitD supply (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) and infection status in broiler chicken 
orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, on femur length (mm), width (mm) and 
breaking strength (N) in proportion to body weight (BW; cg) as well as seedor and robusticity indexes on d6 and 12 post-infection (pi). 
      Femur 
Experimental factors 
Length/BW 
(mm/cg) 
Width/BW (mm/cg) 
Breaking 
Strength/BW 
(N/cg) 
Seedor index Robusticity index 
d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi 
Level 
M 5.95 4.28 0.687 0.512 146 122 80.0 113 3.41 3.35 
A 6.16 4.40 0.719 0.521 171 140 81.7 112 3.39 3.33 
Source 
D3 6.01 4.36 0.691 0.513 164 130 80.2 113 3.41 3.36 
OHD 6.10 4.32 0.715 0.520 153 132 81.6 112 3.39 3.33 
Infection 
Control 5.80 4.15 0.684 0.498 162 140 82.1 115 3.40 3.36 
Infected 6.32 4.53 0.722 0.535 155 122 79.7 110 3.40 3.32 
  SEM 0.0767 0.0646 0.0101 0.0067 5.04 3.77 1.23 1.63 0.0182 0.0173 
   Probabilities 
Level 0.070 0.203 0.030 0.344 0.002 0.002 0.339 0.932 0.490 0.597 
Source 0.441 0.656 0.104 0.458 0.124 0.685 0.454 0.725 0.534 0.246 
Infection <0.001 <0.001 0.011 <0.001 0.338 0.002 0.168 0.034 0.705 0.186 
Level × Source 0.583 0.944 0.674 0.650 0.589 0.052 0.454 0.383 0.653 0.805 
Level × Infection 0.078 0.251 0.636 0.064 0.477 0.596 0.294 0.037 0.595 0.048 
Source × Infection 0.634 0.370 0.639 0.350 0.509 0.316 0.472 0.066 0.736 0.217 
Level × Source × Infection 0.235 0.859 0.941 0.363 0.136 0.470 0.157 0.326 0.187 0.341 
SEM: Pooled standard error of the mean. 602 
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Table 8 Effects of source of VitD supply (D3 vs OHD), Ca/P level (M = 6.1:3.1 vs A = 8.7:4.4 g/kg) and infection status in broiler chicken orally inoculated with 
0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, on tibia length (mm), width (mm), breaking strength (N) and ash weight (mg) 
in proportion to body weight (BW; cg) as well as ash percentage, seedor and robusticity indices on d6 and 12 post-infection (pi). 
      Tibia     
Experimental factors 
Length/BW 
(mm/cg) 
Width/BW 
(mm/cg) 
Breaking 
Strength/BW 
(N/cg) 
Seedor index 
Robusticity 
index 
Ash/BW (mg/g) Ash percentage 
d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi d6pi d12pi 
Level 
M 8.01 5.80 0.619 0.450 214 167 86.7 118 4.05 4.04 0.904 0.909 50.1 50.5 
A 8.23 5.96 0.66 0.455 236 191 86.8 115 4.04 4.04 1.00 0.995 51.7 51.2 
Source 
D3 8.07 5.90 0.639 0.455 227 176 86.4 117 4.05 4.04 0.951 0.946 51.0 50.5 
OHD 8.17 5.86 0.640 0.451 224 182 87.1 115 4.04 4.04 0.955 0.958 50.8 51.2 
Infection 
Control 7.83 5.62 0.623 0.454 230 207 87.8 121 4.06 4.03 0.969 0.992 51.4 52.5 
Infected 8.42 6.15 0.656 0.452 220 151 85.7 111 4.03 4.06 0.937 0.911 50.4 49.2 
  SEM 0.0858 0.0794 0.00965 0.00722 6.01 4.05 1.15 1.78 0.0164 0.017 0.0154 0.0152 0.321 0.308 
   Probabilities 
Level 0.081 0.180 0.006 0.605 0.013 <0.001 0.952 0.338 0.674 0.928 <0.001 <0.001 0.001 0.080 
Source 0.394 0.761 0.992 0.672 0.734 0.306 0.701 0.398 0.690 0.909 0.868 0.587 0.593 0.172 
Infection <0.001 <0.001 0.023 0.851 0.254 <0.001 0.189 <0.001 0.216 0.294 0.145 0.001 0.042 <0.001 
Level × Source 0.426 0.865 0.870 0.734 0.776 0.602 0.143 0.214 0.834 0.274 0.831 0.023 0.740 0.022 
Level × Infection 0.035 0.335 0.084 0.095 0.965 0.024 0.715 0.017 0.363 0.008 0.391 0.528 0.763 0.933 
Source × Infection 0.393 0.348 0.863 0.109 0.502 0.83 0.471 0.143 0.432 0.144 0.750 0.396 0.710 0.904 
Level × Source × Infection 0.171 0.789 0.965 0.326 0.805 0.143 0.123 0.284 0.126 0.965 0.501 0.812 0.948 0.477 
SEM: Pooled standard error of the mean. 603 
See Figures 2 and 3 for graphical illustration of significant interactions (P < 0.05) between the experimental factors at d12pi.  604 
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 605 
 
Figure 1 The interaction between dietary VitD source (D3 and OHD) supplemented at 4000 IU/kg and infection 
status of growing broilers orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) 
at d12 post hatch, on plasma calcium concentration at d6 post-infection (pi). 
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 606 
Figure 2 The interaction between dietary Ca/P level (A = 8.7:4.4 vs M = 6.1:3.1) and infection status of growing 607 
broilers orally inoculated with 0 (Control) or 7000 sporulated oocysts of E. maxima (Infected) at d12 post hatch, 608 
on tibia bone breaking strength in proportion to body weight (BS/BW) at d12 post-infection (pi).  609 
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 610 
Figure 3 The interaction between dietary VitD source (D3 and OHD) supplemented at 4000 IU/kg and dietary 611 
Ca/P level (A = 8.7:4.4 vs M = 6.1:3.1) of growing broilers orally inoculated with 0 (Control) or 7000 sporulated 612 
oocysts of E. maxima (Infected) at d12 post hatch, on tibia ash percentage (A) and ash in proportion to body 613 
weight (B) at d12 post-infection (pi). 614 
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